GFAP and Alzheimer disease: We additionally assessed the link between eCBs and the following novel AD and neurodegeneration/neuro-injury blood biomarkers: total tau (t-tau), neurofilament light (NfL), glial fibrillary acidic protein (GFAP), and ubiquitin C-terminal hydrolase L1 (UCH-L1).